Claims for Patent: 9,192,112

Summary for Patent: 9,192,112

Title:	Methods for producing hybrid seed
Abstract:	This invention provides methods for producing a non-natural hybrid seed. Also disclosed are specific miRNAs and miRNA recognition sites useful for conferring inducible sterility on a crop plant, and recombinant DNA construct including such exogenous miRNA recognition sites.
Inventor(s):	Allen; Edwards (O\'Fallon, MO), Gilbertson; Larry A (Chesterfield, MO), Roberts; James K (Chesterfield, MO), Houmard; Nancy M (North Stonington, CT), Huang; Shihshieh (Woodland, CA), Ivashuta; Sergey (Ballwin, MO)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	13/677,607
Patent Claims:	1. A method of inducing male sterility in a transgenic plant comprising applying herbicide to a transgenic plant having in its genome a recombinant DNA construct that transcribes to RNA comprising (a) at least one exogenous miRNA recognition site recognizable by an endogenous mature miRNA that is specifically expressed in male reproductive tissue of said transgenic plant, and (b) messenger RNA encoding a protein imparting tolerance to said herbicide, said herbicide being applied under a regime sufficient to induce male sterility in said transgenic plant. 2. The method of claim 1, wherein said herbicide is a systemic herbicide. 3. The method of claim 1, wherein said protein imparting tolerance is at least one protein selected from the group consisting of an 5-enolpyruvylshikimate-3-phosphate synthase, the 5-enolpyruvylshikimate-3-phosphate synthase from Agrobacterium tumefaciens strain CP4, glyphosate oxidoreductase, glyphosate acetyltransferase, glyphosate decarboxylase, pat, bar, dicamba monooxygenase, 2,2-dichloropropionic acid dehalogenase, acetohydroxyacid synthase, acetolactate synthase, haloarylnitrilase, modified acetyl-coenzyme A carboxylase, dihydropteroate synthase, 32 kDa photosystem II polypeptide, anthranilate synthase, dihydrodipicolinic acid synthase, phytoene desaturase, hydroxyphenyl pyruvate dioxygenase, modified protoporphyrinogen oxidase I, and aryloxyalkanoate dioxygenase. 4. The method of claim 1, wherein said exogenous miRNA recognition site is located within at least one of: (a) the 5' untranslated region of said messenger RNA; (b) the 3' untranslated region of said messenger RNA; and (c) the coding region of said messenger RNA. 5. The method of claim 1, wherein said recombinant DNA construct further comprises at least one element selected from the group consisting of: (a) a plant promoter (b) a gene suppression element; (c) an intron; (d) a gene expression element; (e) DNA that transcribes to an RNA aptamer capable of binding to a ligand; (f) DNA that transcribes to an RNA aptamer capable of binding to a ligand and DNA that transcribes to regulatory RNA capable of regulating expression of a target sequence, characterized in that said regulation is dependent on the conformation of said regulatory RNA, and said conformation of said regulatory RNA is allosterically affected by the binding state of said RNA aptamer; and (g) at least one T-DNA border. 6. The method of claim 1, wherein said transgenic plant is selected from the group consisting of maize, soybean, cotton, and wheat. 7. A male-sterile transgenic plant obtained by the method of claim 1. 8. Transgenic progeny seed of the male-sterile transgenic plant of claim 7, wherein said transgenic progeny seed contains in its genome said recombinant DNA construct. 9. A method of providing a male-sterile transgenic crop plant, comprising the steps of: (a) identifying an endogenous mature miRNA that is specifically expressed in male reproductive tissue of a crop plant; (b) stably transforming said crop plant with a recombinant DNA construct comprising a promoter operably linked to DNA that transcribes to RNA comprising (i) at least one exogenous miRNA recognition site recognizable by said endogenous mature miRNA, and (ii) messenger RNA encoding a protein imparting tolerance to an herbicide, thereby providing a transgenic crop plant; and (c) applying to said transgenic crop plant said herbicide under a regime sufficient induce male sterility in said transgenic crop plant. 10. The method of claim 9, wherein said herbicide is a systemic herbicide. 11. The method of claim 9, wherein said protein imparting tolerance is at least one protein selected from the group consisting of an 5-enolpyruvylshikimate-3-phosphate synthase, the 5-enolpyruvylshikimate-3-phosphate synthase from Agrobacterium tumefaciens strain CP4, glyphosate oxidoreductase, glyphosate acetyltransferase, glyphosate decarboxylase, pat, bar, dicamba monooxygenase, 2,2-dichloropropionic acid dehalogenase, acetohydroxyacid synthase, acetolactate synthase, haloarylnitrilase, modified acetyl-coenzyme A carboxylase, dihydropteroate synthase, 32 kDa photosystem II polypeptide, anthranilate synthase, dihydrodipicolinic acid synthase, phytoene desaturase, hydroxyphenyl pyruvate dioxygenase, modified protoporphyrinogen oxidase I, and aryloxyalkanoate dioxygenase. 12. The method of claim 9, wherein said exogenous miRNA recognition site is located within at least one of: (a) the 5' untranslated region of said messenger RNA; (b) the 3' untranslated region of said messenger RNA; and (c) the coding region of said first messenger RNA. 13. The method of claim 9, wherein said recombinant DNA construct further comprises at least one element selected from the group consisting of: (a) a gene suppression element; (b) an intron; (c) a gene expression element; (d) DNA that transcribes to an RNA aptamer capable of binding to a ligand; (e) DNA that transcribes to an RNA aptamer capable of binding to a ligand and DNA that transcribes to regulatory RNA capable of regulating expression of a target sequence, characterized in that said regulation is dependent on the conformation of said regulatory RNA, and said conformation of said regulatory RNA is allosterically affected by the binding state of said RNA aptamer; and (f) at least one T-DNA border. 14. The method of claim 9, wherein said transgenic crop plant is selected from the group consisting of maize, soybean, cotton, and wheat.

Details for Patent 9,192,112

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26